Nolan Garry Ph.D.

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Nolan Garry Ph.D.'s trades of Akoya Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-06 2022-12-02
S Sale
61,475 -25.3%
287.30
US$1,179,798 		61,475 -25.3% 287.30 US$1,179,798
2022-12-02 2022-12-01
S Sale
52,598 -49.0%
53.62
US$3,926,308 		52,598 -49.0% 53.62 US$3,926,308
2022-11-17 2022-11-16
S Sale
42,817 +24.9%
406.60
US$1,906,898 		42,817 +24.9% 406.60 US$1,906,898
2022-11-14 2022-11-14
S Sale
600 -0.1%
13.28
US$7,966 		600 -0.1% 13.28 US$7,966
2022-11-14 2022-11-11
S Sale
20,000 -3.2%
13.29
US$265,858 		20,000 -3.2% 13.29 US$265,858
2022-11-14 2022-11-10
S Sale
3,810 -0.6%
13.31
US$50,705 		3,810 -0.6% 13.31 US$50,705
2022-09-16 2022-09-14
S Sale
8,305 -1.3%
13.26
US$110,084 		8,305 -1.3% 13.26 US$110,084
2022-09-13 2022-09-12
S Sale
1,800 -0.3%
13.30
US$23,944 		1,800 -0.3% 13.30 US$23,944
2022-09-13 2022-09-09
S Sale
22,191 -3.4%
13.31
US$295,338 		22,191 -3.4% 13.31 US$295,338
2022-12-15 2021-12-13
S Sale
100 -0.0%
13.25
US$1,325 		100 -0.0% 13.25 US$1,325
2021-12-13 2021-12-09
S Sale
25,000 -3.7%
12.67
US$316,762 		25,000 -3.7% 12.67 US$316,762